- US-listed companies
- Medpace Holdings, Inc.
- Income statement
Medpace Holdings, Inc.【MEDP】Income statement
Market cap
$16.7B
P/E ratio
| 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Revenue | 422 | 436 | 705 | 861 | 926 | 1,142 | 1,460 | 1,886 | 2,109 |
| Revenue growth (%) | - | ||||||||
| Selling, general & administrative | 62 | 63 | 76 | 95 | 92 | 108 | 131 | 161 | 180 |
| Operating margin (%) | |||||||||
| Operating income | 52 | 65 | 101 | 127 | 167 | 199 | 279 | 337 | 447 |
| Operating expenses | 369 | 371 | 604 | 734 | 759 | 944 | 1,181 | 1,549 | 1,662 |
| Income before tax | 22 | 57 | 94 | 125 | 169 | 202 | 283 | 336 | 476 |
| Pretax margin (%) | 5.2 | 13.1 | 13.3 | 14.5 | 18.2 | 17.7 | 19.4 | 17.8 | 22.6 |
| Provision for income taxes | 9 | 18 | 21 | 24 | 23 | 20 | 37 | 53 | 72 |
| Effective tax rate (%) | |||||||||
| Net income | 13 | 39 | 73 | 100 | 145 | 182 | 245 | 283 | 404 |
| Net income margin (%) | |||||||||
| Earnings per share | 0.38 | 1 | 2.05 | 2.79 | 4.07 | 5.06 | 7.57 | 9.2 | 13.06 |
| Diluted EPS | 0.37 | 0.98 | 1.97 | 2.67 | 3.84 | 4.81 | 7.28 | 8.88 | 12.63 |